Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 16 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Document-related representative information
Liquid crystal display panel
Method and composition for attracting arthropods by volatizing an acid
Vibration power generator and vibration power generation device, and communication device and electronic equipment with vibration power generation device
Method and system for phase-sensitive magnetic resonance imaging
Monitoring device for monitoring a display device
Processing data using information embedded in a data request
  Randomly Featured Patents
Instrument for measuring a length
System and method for three-dimensional interaction based on gaze and system and method for tracking three-dimensional gaze
Inkjet recording apparatus and inkjet recording method
Matrix acidizing high permeability contrast formations
Use of anti-IL-20 antibody for treating stroke
Treatment of geothermal brine sulfate-rich fluids to facilitate the precipitation of silica
Wedge-shaped gaming machine
Apparatus and methods for determining the concentration of black carbon particles in a combustion exhaust
Triphenylamine derivative, charge-transporting material comprising the same, and electrophotographic photoreceptor